Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

ABPI respond to government announcement of £86 million to speed up patient access to innovative medicines and technology

Posted on: 17 Jul 17

The Association of the British Pharmaceutical Industry (ABPI) have responded to an announcement made today by Lord Health Minister Lord O’Shaughnessy to spend £86 million "to help develop real world medical breakthroughs that will help patients across the NHS."

It’s important to put significant government investment where it counts, and speeding up patients’ access to new medicines and treatments is one route to healthier lives for us all.

As more and more small and medium-sized innovators join the ABPI, we continue to encourage and advocate ways to make groundbreaking, cost-effective healthcare technologies available as fast as possible. In doing so, patients will not only benefit from improved care, but the NHS will also become more productive and more sustainable in the long term.

Academic Health Science Network’s (ASHNs) are a critical delivery partner for bringing the Accelerated Access Review (AAR) to life, and £39 million of investment is an important first step in pulling industry and the health service together to realise the Review’s ambition.

Turning the rest of the AAR’s recommendations into reality now relies on a full, positive Government response to the Review – and an effective Life Sciences Industrial Strategy.

If we get this right, fostering greater collaboration between innovators, patients, NICE and the NHS can make the UK the world leading hub for Life Sciences."

Dr Richard Torbett, Executive Director of Commercial Policy, ABPI

Media enquiries

ABPI Press Office
Telephone (24hrs): +44 (0) 20 7747 7147 

Editor's Details

Mike Wood

Last updated on: 17/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.